Wednesday, November 18, 2026

FDA Class II: Victory Medical Center Pharmacy Recalls CJC-1295/IPAMORELIN (MDV) 2/2MG/ML **5ML**, VMC, Victory Medical Center Pharmacy

Class II announced by FDA for CJC-1295/IPAMORELIN (MDV) 2/2MG/ML **5ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas. Reason: Lack of Processing Controls...

NewsKrez Editorial DeskNovember 10, 2026 • 6:30 PM UTC
3 min read20 views
FDA Class II: Victory Medical Center Pharmacy Recalls CJC-1295/IPAMORELIN (MDV) 2/2MG/ML **5ML**, VMC, Victory Medical Center Pharmacy
Pharmaceutical product recall and laboratory testing.

The U.S. Food and Drug Administration (FDA) has posted an official drug enforcement report concerning Victory Medical Center Pharmacy.

Product and Classification Details

  • Recall Number: D-0125-2027
  • Classification: Class II
  • Recalling Firm: Victory Medical Center Pharmacy
  • Status: Ongoing

Reason for Enforcement Action

Lack of Processing Controls

Distribution Information

CO, FL, TX

Official notification published per FDA Center for Drug Evaluation and Research (CDER) surveillance databases.
Regulatory Verification & Source Attribution

This intelligence report was compiled and verified by the NewsKrez Editorial & Regulatory Intelligence Desk in conjunction with openFDA Drug Enforcement & Recalls.

Sponsored Intelligence
Medical Device Software Compliance

Automated 21 CFR Part 820 & ISO 13485 Verification

Explore Solution →